Chemomab Therapeutics Ltd.

CMMB ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Oct 19, 2026 6-K
S-4/A Oct 19, 2026 S-4/A
6-K Sep 30, 2026 6-K
S-4 Sep 25, 2026 S-4
SCHEDULE 13D/A Sep 9, 2026
4 Sep 1, 2026
6-K Aug 19, 2026 6-K
SCHEDULE 13G Aug 13, 2026
DRS Aug 12, 2026
SCHEDULE 13G/A Aug 10, 2026
SCHEDULE 13D Jul 16, 2026
6-K Jul 8, 2026 6-K
3 Jun 3, 2026 FORM 3
6-K Jun 2, 2026 6-K
4 Jun 1, 2026
6-K May 14, 2026 6-K
6-K May 6, 2026 6-K
6-K Apr 28, 2026 6-K
3 Apr 10, 2026
3 Apr 10, 2026 FORM 3
3 Apr 10, 2026
3 Apr 10, 2026
3 Apr 10, 2026
3 Apr 10, 2026
3 Mar 31, 2026
← Newer Page 1 of 15 · 362 filings Older →